IRF4 and Miyoshi myopathy: CBP/EP300 bromodomaininhibition was sufficient to reduce IRF4 mRNA levels but not IRF4protein levels, which might partly be explained by the long half-lifeof IRF4 in MM cell lines (33–61 h), compared to the short half-lifeof c-Myc (30 min).12